Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$179.4M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM LEGH
FY Dec 2025
$164.6M
FY Dec 2024
$184.2M
FY Dec 2023
$189.1M
FY Dec 2022
$257.0M
FY Dec 2021
$197.5M
Jun 2026
$66.3M
Mar 2026
$34.4M
Dec 2025
$38.3M
Sep 2025
$40.5M
Jun 2025
$50.2M
Mar 2025
$35.7M
Dec 2024
$54.2M
Sep 2024
$44.3M
At each fiscal year end
Single quarter
Net margin, TTM
+28.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM LEGH
FY Dec 2025
+25.4%
FY Dec 2024
+33.5%
FY Dec 2023
+28.8%
FY Dec 2022
+26.4%
FY Dec 2021
+25.3%
Jun 2026
+35.4%
Mar 2026
+31.8%
Dec 2025
+21.4%
Sep 2025
+21.4%
Jun 2025
+29.3%
Mar 2025
+28.8%
Dec 2024
+26.8%
Sep 2024
+35.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$38.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM LEGH
FY Dec 2025
$28.2M
FY Dec 2024
$26.8M
FY Dec 2023
-$21.2M
FY Dec 2022
-$5.5M
FY Dec 2021
$54.3M
Jun 2026
$12.3M
Mar 2026
$5.4M
Dec 2025
$15.7M
Sep 2025
$5.1M
Jun 2025
$3.7M
Mar 2025
$3.6M
Dec 2024
$6.0M
Sep 2024
$9.1M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity LEGH
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt LEGH
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+9.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity LEGH
FY Dec 2025
+8.2%
FY Dec 2024
+13.2%
FY Dec 2023
+13.3%
FY Dec 2022
+19.6%
FY Dec 2021
+17.5%
Jun 2026
+9.5%
Mar 2026
+8.1%
Dec 2025
+8.2%
Sep 2025
+9.6%
Jun 2025
+11.3%
Mar 2025
+11.9%
Dec 2024
+13.2%
Sep 2024
+11.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+8.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets LEGH
FY Dec 2025
+7.5%
FY Dec 2024
+11.8%
FY Dec 2023
+11.5%
FY Dec 2022
+16.9%
FY Dec 2021
+14.1%
Jun 2026
+8.8%
Mar 2026
+7.5%
Dec 2025
+7.5%
Sep 2025
+8.9%
Jun 2025
+10.4%
Mar 2025
+10.8%
Dec 2024
+11.8%
Sep 2024
+10.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital LEGH
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+10.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed LEGH
FY Dec 2025
+9.4%
FY Dec 2024
+13.1%
FY Dec 2023
+14.9%
FY Dec 2022
+21.7%
FY Dec 2021
+18.8%
Jun 2026
+10.8%
Mar 2026
+9.3%
Dec 2025
+9.4%
Sep 2025
+10.5%
Jun 2025
+11.8%
Mar 2025
+11.9%
Dec 2024
+13.1%
Sep 2024
+12.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
13.02x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing LEGH
FY Dec 2025
11.28x
FY Dec 2024
9.99x
FY Dec 2023
11.62x
FY Dec 2022
6.92x
FY Dec 2021
12.91x
Jun 2026
12.11x
Mar 2026
11.48x
Dec 2025
11.28x
Sep 2025
14.18x
Jun 2025
10.16x
Mar 2025
11.06x
Dec 2024
9.99x
Sep 2024
12.60x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value LEGH
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield LEGH
FY Dec 2025
+6.0%
FY Dec 2024
+4.5%
FY Dec 2023
-3.5%
FY Dec 2022
-1.2%
FY Dec 2021
+8.5%
Jun 2026
+6.2%
Mar 2026
+6.2%
Dec 2025
+6.0%
Sep 2025
+2.8%
Jun 2025
+4.1%
Mar 2025
+3.4%
Dec 2024
+4.5%
Sep 2024
+1.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -3%, PEG needs growth
PEG, trailing LEGH
FY Dec 2025
n/a
FY Dec 2024
0.72x
FY Dec 2023
n/a
FY Dec 2022
0.21x
FY Dec 2021
0.42x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
3.68x
Mar 2025
1.47x
Dec 2024
0.72x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
LEGH ranks highest on profitability (69th percentile) and risk and compliance (65th), and lowest on growth (17th), among Materials peers.
Profitability
69
Inputs
Return on equity+9.5% · 59 pct, sector of 100
Return on assets+8.8% · 82 pct, sector of 120
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed+10.8% · 66 pct, sector of 96
Growth
17
Inputs
Revenue growth, YoY-9.6% · 17 pct, sector of 128
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
32
Inputs
Funds adding, latest quarter67 · 32 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
65
Inputs
Short interest, % of float+7.2% · 30 pct, sector of 143
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Insider conviction, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.